Sanofi’s Boehringer deal will boost launches

Sanofi’s Boehringer deal will boost launches

4 July 2016 - Deborah Wilkes

Download this NEWS EXTRA publication to find out how Sanofi expects its acquisition of Boehringer Ingelheim’s Consumer Health Care business to give it a stronger global platform for launching prescription-to-OTC switches and other OTC innovations.

This News Extra covers:
- Profitability expectations
- OTC switch opportunities, including Cialis
- Sanofi’s “unique” OTC business model
- Geographic presence
- Key brands in the combined business
- Acquisition plans

The publication includes comments from Vincent Warnery, senior vice-president of Sanofi’s Global Consumer Healthcare business unit.

It is available to purchase and download immediately from the OTCToolbox website. You can make sure your team is well informed through a Multiple User Licence or a Global Licence.

The News Extra is available free to people with an Annual Subscription to the OTCToolbox website (click here to find out more).



RAPID INSIGHTS MADE EASY
AVAILABLE TO DOWNLOAD IMMEDIATELY AS A PDF
See Payment Options box at the top of this page

For alternative payment options and delivery methods, or other questions, please send an email to enquiries@otctoolbox.com.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to News Extras

Share this page: